U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07041606) titled 'An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation' on June 06.
Brief Summary: Multicenter, observational, prospective study of molecular profiling in advanced and aggressive endometrial cancer patients and 1-st line treatment approaches in Russian Federation
Study Start Date: June 30
Study Type: OBSERVATIONAL
Condition:
Endometrial Cancer
Recruitment Status: NOT_YET_RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....